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Summary Cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) is a
potential life-threatening disease. Identiﬁcation of patients at risk for CHS commonly takes
place with use of intra-operative transcranial Doppler (TCD), but is associated with both false
positive and false negative results. We aimed to determine the diagnostic value for predicting
CHS, by adding a TCD measurement in the early post-operative phase after CEA.
We retrospectively included 72 patients who underwent CEA between January 2004 and
August 2010 and in whom both intra- and post-operative TCD of the ipsilateral middle cerebral
artery monitoring were performed. Twelve patients (17%) had an intra-operative mean blood
ﬂow velocity (Vmean) increase >100% and 13 patients (18%) a post-operative Vmean increase of
>100%. In 5 patients (7%) CHS was diagnosed; 2 of those had an intra-operative Vmean increase
of >100% and all 5 a post-operative Vmean increase >100%. This results in a positive predictive
value of 17% for the intra-operative and 38% for the post-operative measurement.
In conclusion, a post-operative increase of the mean velocity in the ipsilateral middle cerebral
artery of >100% as measured by TCD is superior to an intra-operative velocity increase, for the
identiﬁcation of patients at risk for the development of CHS after CEA.
© 2012 Elsevier GmbH.
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Table 1 Patient characteristics.
Patient characteristics N = 72; mean± SD
Age (years) 68.4 (± 10.1)
Gender (male) 53 (74%)
Site (right) 36 (50%)
Symptomatic 62 (86%)
Shunt use 22 (31%)
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ntroduction
erebral hyperperfusion syndrome (CHS) after carotid
ndarterectomy (CEA) is a potential life-threatening dis-
ase. It is deﬁned by a combination of symptoms, including
eadache, vomiting, neurological deﬁcit or seizures, and
t least a doubling of pre-operative cerebral blood ﬂow.
HS can occur during the ﬁrst few days up to four weeks
fter CEA in 1—3% of patients [1]. If not recognized and
reated adequately in time (i.e., strict blood pressure con-
rol), hemorrhagic stroke may occur, which subsequently
eads to death in up to 40% of patients [2].
The generally accepted deﬁnition of post-operative cere-
ral hyperperfusion in the context of CEA is deﬁned as an
ncrease in cerebral blood ﬂow (CBF) of >100% over baseline
3]. This occurs in approximately 10% of CEA patients [4]
nd has been associated with a tenfold higher risk for post-
perative intra-cerebral hemorrhage in patients operated
nder general anesthesia [3,5]. Changes in CBF are corre-
ated with changes in the mean blood velocity (Vmean) in
he ipsilateral middle cerebral artery (MCA) as measured
ith TCD [6,7]. Currently, during CEA under general anes-
hesia, an increase in Vmean of >100% three minutes after
eclamping the ICA, compared to the pre-clamping Vmean is
he most commonly used predictor of CHS [2,8—10]. How-
ver, intra-operative TCD monitoring is associated with both
alse negative and false positive results [2,11]. Therefore,
more precise method is needed to predict which patients
re at risk for CHS [12].
This study aimed to assess the predictive values of TCD
onitoring regarding the development of CHS, by intro-
ucing an additional TCD measurement in the ﬁrst two
ost-operative hours.
ethods
atients who underwent CEA between January 2004 and
ugust 2010 in the St. Antonius Hospital, Nieuwegein, The
etherlands, were retrospectively included. All patients
ho underwent CEA for a high degree ICA stenosis and in
hom both intra- and post-operative TCD monitoring were
erformed were included.
Surgery was performed under general anesthesia and all
atients received the same anesthetic regimen. An intra-
uminal shunt was used selectively in case of EEG asymmetry
r a decrease of >60% of Vmean measured by TCD [13].
For the TCD registration, a pulsed Doppler transducer
Pioneer TC4040, EME, Überlingen, Germany), gated at a
ocal depth of 45—60mm, was placed over the temporal
one to insonate the main stem of the MCA ipsilateral to
he treated carotid artery. The TCD transducer was ﬁxed
ith a head frame and Vmean was recorded continuously.
Vmean values at the following time points were used
or further analysis. For the pre-operative Vmean (V1), a
CD measurement was performed 1—3 days prior to oper-
tion. During operation, the pre-clamping Vmean (V2) was
egistered 30 s prior to carotid cross-clamping. The post-
eclamping Vmean (V3) was determined three minutes after
eclamping. An additional post-operative Vmean (V4) was
easured within the ﬁrst 2 h after surgery on the recov-
ry ward. The intra-operative increase of Vmean was deﬁned
h
l
i
pPost-operative hypertension 19 (26%)
Cerebral hyperperfusion syndrome 5 (7%)
nd calculated as (V3−V2)/V2× 100%. For calculating the
ost-operative increase of Vmean the following formula was
sed (V4−V1)/V1× 100%. The positive (PPV) and negative
redictive values (NPV) of both intra-operative and post-
perative increase of Vmean were calculated.
All patients with post-operative hypertension, i.e. blood
ressure (BP) >160mmHg systolic (absolute), >20% above
he pre-operative BP, or BP risen above the individual
estriction in patients with an intra-operative Vmean increase
100%, underwent strict individualized BP control during the
arly post-operative period with intravenous labetalol (ﬁrst
hoice) or clonidine (second choice).
CHS was diagnosed if the patient developed headache,
onfusion, seizures, intracranial hemorrhage or focal neu-
ological deﬁcits in the presence of post-operative cerebral
yperperfusion (deﬁned as >100% increase of the pre-
perative Vmean) after a symptom-free interval.
esults
f the 560 patients undergoing CEA during the time of
he study, 72 (13%) received both intra- and post-operative
CD monitoring and were included for the present analy-
is. See Table 1 for patient characteristics. The majority
f patients were symptomatic (86%). About a third of the
atients required the use of an intra-luminal shunt because
f either EEG asymmetry or a decrease of >60% of Vmean
easured by TCD.
Twelve patients (17%) had an intra-operative Vmean
ncrease >100%. Post-operatively, Vmean increase >100% was
ound in the 13 patients (18%).
During all TCD measurements no signiﬁcant increase in BP
as found after declamping compared to the pre-clamping
ystolic BP or when the post-operative measurement was
ompared to the pre-operative systolic BP.
Of all 72 patients, 19 patients (26%) developed post-
perative hypertension and 5 patients (7%) suffered from
HS. All patients with CHS had hypertension during the post-
perative phase. The overall 30-day rate of death/stroke
as 1%.
CD measurements and clinical outcome
f 12 patients with an intra-operative increase of
mean > 100%, 2 patients developed CHS. On the other
and, in 60 patients who had an intra-operative increase
ess than 100%, 3 patients suffered from CHS. This results
n a PPV of 17% (2/12) and NPV of 95% (57/60) in the
rediction of CHS (Table 2).
When to perform TCD to predict cerebral hyperperfusion after C
Table 2 Cross tables for predictive values of intra- or post-
operative TCD measurements for the occurrence of CHS.
CHS+ CHS− PPV (%) NPV (%)
Intra-operative increase
>100% 2 (3%) 10 (14%) 17 95
<100% 3 (4%) 57 (79%)
Post-operative increase
>100% 5 (7%) 8 (11%) 38 100
<100% 0 (0%) 59 (82%)
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[CHS+: number of patients who developed CHS (%); CHS−: number
of patients who did not develop CHS (%); PPV: positive predictive
value (%); NPV: negative predictive value (%).
With respect to the post-operative TCD measurements 5
of the 13 patients with at least a doubling of post-operative
Vmean developed CHS. In the subgroup of 59 patients with a
post-operative increase of less than 100% CHS did not occur.
This results in a PPV of 38% (5/13) and a NPV of 100% (59/59)
for the development of CHS.
Discussion
In the present retrospective study, as previously pub-
lished, an increase in Vmean measured with post-operative
TCD is superior in predicting the development of CHS
to the commonly used increase in Vmean measured three
minutes after declamping versus pre-clamping value [12].
The PPV of the post-operative measurement in the pre-
diction of CHS is more than two times higher than the
PPV of the intra-operative measurement (38% and 17%
respectively). Moreover, absence of doubling of the Vmean
at the post-operative measurement completely excluded
the development of CHS (NPV 95% vs. 100% for the
intra-operative and post-operative measurements, respec-
tively). Therefore, with post-operative measurement fewer
patients will be treated unnecessarily by strict intravenous
antihypertensive medication. These observations need con-
ﬁrmation in larger patients cohorts, with special focus on
the optimal threshold of post-operative CHS prediction.
In our study, only 5 of all patients developed CHS. The
low incidence of CHS hampers the interpretation of our
results. However, the incidence in our group of patients
(7%) is relatively high compared to other series. This might
be explained by the fact that in our referral hospital a
selected group of patients with relatively severe hemody-
namic compromise are treated, which is also reﬂected in
the relatively high number of patients in whom a shunt was
used (31%). In addition, data were collected retrospectively,
and were more likely to be complete (i.e., including post-
operative measurements) in patients with an intra-operative
Vmean increase of >100%, or in patients who developed
post-operative hypertension. However, prospectively col-
lected data in another large vascular training hospital show
similar results and thus conﬁrm our ﬁndings [12]. A mul-
ticenter prospective study to optimize the post-operative
TCD-measurements will start in 2012.Conclusion
Besides the commonly used intra-operative TCD monitor-
ing, additional TCD measurement in the early post-operativeEA 121
hase is useful to predict CHS in patients that underwent
EA under general anesthesia. By measuring Vmean in the
ost-operative instead of only in the intra-operative phase,
oth the positive and negative predictive value of TCD for
evelopment of CHS after CEA can be improved. Therefore,
e recommend a baseline measurement before the admin-
stration of anesthetics and a post-operative measurement
ithin two hours after surgery.
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